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Nearly 40 years ago, the association between breastfeeding and prolongation of unconjugated hyperbilirubinemia in the newborn was recognized simultaneously by two separate groups of investigators. 1, 2 Initially, it was thought to be a relatively rare clinical situation, which occurred in only 1% of all breastfed neonates. Later studies in both England and in the United States demonstrated that at least one third of all breastfed infants are clinically jaundiced in the third week of life and that two thirds have significant unconjugated hyperbilirubinemia in the third week. This contrasts to the absence of hyperbilirubinemia in the third week in full-term artificially fed infants 3 -5 ( Figure 1 ). What was once thought to be a clinical disorder has now been recognized to be a normally occurring extension of physiologic jaundice of the newborn.
The optimally breastfed infant does not differ from the artificially fed infant in serum bilirubin concentrations during the first 5 days of life. Optimal breastfeeding management includes initiation of breastfeeding in the first hour, followed by at least 10 to 12 breastfeeds per day for the first 1 to 2 weeks without any water or other food supplementation, using good positioning that assures effective milk transfer to the infant, and weight loss from birth of less than 8%. 6 After the fifth day, the great majority of breastfed infants either maintain a stable, but elevated serum bilirubin level, or have a second rise in bilirubin, which generally peaks on about the 10th to 15th days of life 7 ( Figure 2 ). In some infants, these elevated levels may continue for many weeks, whereas in others, the levels decline during the third and fourth weeks. During the third week of life, among the two thirds or more with elevated levels, the serum bilirubin concentrations may range from just over the upper limit of adult normal, 25 M/l (1.5 mg/dl), to more than 250 M/l (15 mg/dl) ( Figure 3) . Rarely do the levels in healthy, term infants rise beyond 25 mg/dl (425 M/l) or place the infant at risk for bilirubin encephalopathy. Ultimately, serum bilirubin levels return to normal in all infants with breastmilk jaundice. Persistence of hyperbilirubinemia beyond 3 months would suggest an etiology other than breastmilk.
The mechanism of breastmilk jaundice has generated a vast array of hypotheses, ranging from our own original concept that human milk contained an inhibitor of hepatic glucuronyl transferase, the enzyme promoting the conjugation of bilirubin with glucuronic acid, and that blockage at the step of bilirubin conjugation was responsible for the ''disorder.'' This concept was supported by the detection of an unusual metabolite of progesterone, pregnane-3(alpha),20(beta)-diol, which was shown to be an inhibitor of hepatic glucuronyl transferase in vitro. 1 The presence of this metabolite in milk and maternal urine was confirmed by some, but not all, subsequent investigators. The inhibitory effect of milk on the conjugating enzyme in vitro did not correlate closely with the time course of hyperbilirubinemia in the infants, although it was postulated that the effect of the inhibitor diminished as the children aged. 8 Administration of the pure metabolite to two anicteric, normal term infants at 6 and 8 days of age was associated with a significant increase in serum unconjugated bilirubin concentrations to 87 M/l (5.1 mg/dl) and 146 M/l (8.6 mg/dl), respectively. 8 Subsequent attempts by other investigators to demonstrate that the steroid metabolite would produce clinical jaundice, or an increase in serum bilirubin concentrations in infants were unsuccessful, however. Now that we recognize the universality of breastmilk jaundice in all populations and in the great majority of infants, it appears less likely that
In the breastfed infant, prolongation of unconjugated hyperbilirubinemia into the third and later weeks of life in the healthy newborn is a normal and regularly occurring extension of physiologic jaundice. This is known as breastmilk jaundice. A factor in human milk increases the enterohepatic circulation of bilirubin. Insufficient caloric intake resulting from maternal and / or infant breastfeeding difficulties may also increase serum unconjugated bilirubin concentrations. This is the infantile equivalent of adult starvation jaundice. It is known as breastfeeding jaundice or ''breast -nonfeeding jaundice.'' This increase in severity of physiologic jaundice of the newborn also results from increased enterohepatic circulation of bilirubin, but not because of a factor in human milk. In extreme cases, it may place the infant at risk for development of bilirubin encephalopathy. Optimal breastfeeding practices, which result in minimal initial weight loss and early onset of weight gain, are associated with both reduced breastfeeding jaundice and minimization of the intensity of breastmilk jaundice. 
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pregnanediol is the primary etiologic agent of the jaundice, although it may play some contributory role. A wide range of other hypotheses rapidly followed this initial one. Most of them also focused on inhibition of conjugation as the likely mechanism, but suggested other inhibitors, most prominently increased free fatty acid concentrations resulting from excessive lipase activity in milk. 9, 10 Other putative agents include excessive taurine through its effect on bile acid metabolism and excessive -glucuronidase activity in milk, promoting increased bilirubin glucuronide hydrolysis and an increase in the enterohepatic circulation of bilirubin. 11, 12 None of these etiologies for breastmilk jaundice has stood the test of time, however.
4,13
The most attractive and convincing evidence regarding the mechanism of breastmilk jaundice has come from studies of the effect of human milk on the intestinal absorption of bilirubin with resultant increase in enterohepatic circulation of bilirubin. Using an adult rat model, administration of 17 M (1.0 mg) of unconjugated bilirubin into the duodenum resulted in intestinal absorption of 25% of the dose in 5 hours and no further absorption thereafter. 14 The addition of cow's milk and some human milk to the test dose of bilirubin completely inhibited intestinal absorption of bilirubin. However, milk from mothers of infants with classical breastmilk jaundice inhibited intestinal absorption of bilirubin only for the first 2 hours and was then followed by a dramatic increase in absorption, which continued for at least an additional 14 hours and resulted in a total absorption of 60% of the intestinal bilirubin dose. A subsequent study by other investigators confirmed the role of human milk enhancement of intestinal bilirubin absorption and demonstrated a significant positive correlation between the degree of enhancement of bilirubin absorption in the rat model by the human mother's milk and the infant's serum bilirubin elevation. They found no evidence for the effect of human milk inhibition of glucuronide conjugation of bilirubin, or for the roles of -glucuronidase or free fatty acids in the etiology of breastmilk jaundice. 4 The factor in human milk that increases intestinal bilirubin absorption remains unidentified. Breastmilk jaundice does not present in the first 5 days of life, apparently because the factor in human milk inducing an increase in intestinal absorption of bilirubin does not appear until the transition from colostrum to mature milk. We have concluded that breastmilk jaundice is neither a disease nor a syndrome, but rather a normal developmental phenomenon in the breastfed infant. It is an extension of physiologic jaundice of the newborn.
DIAGNOSIS OF BREASTMILK JAUNDICE
Recognition that at least two thirds of all breastfed infants will have serum bilirubin concentrations in the third week of life that are significantly higher than the adult normal value is an important foundation for diagnosis. Breastmilk jaundice is a normal, regularly occurring prolongation of physiologic jaundice of the newborn. For the healthy, full-term infant, elevations of serum unconjugated 
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Breastfeeding and Jaundice bilirubin to 340 or 425 M/l (20 or 25 mg/dl), the highest levels seen with breastmilk jaundice, are not a cause for alarm, although they indicate a need for investigation to rule out pathologic causes of exaggerated hyperbilirubinemia. Elevations to this level are rare, occurring in fewer than 1% of all thriving breastfed infants. The great majority of infants with breastmilk jaundice will have much lower levels ( Figure 3) . 4 Only one third has levels greater than 100 M/l (6 mg/dl) and the great majority of breastfed infants with elevated bilirubin concentrations have less than 150 M/l (9 mg/dl). 4 The recent report by Maruo et al. 15 from Japan provides strong evidence that most of the breastfed infants with these very high levels have a genetic factor which contributes to their extreme hyperbilirubinemia by restricting the hepatic conjugation of bilirubin. The diagnosis of breastmilk jaundice can usually be made in the healthy, thriving breastfed infant with good weight gain in whom hemolysis and other pathologic causes of jaundice have been ruled out by clinical or laboratory study.
CLINICAL MANAGEMENT OF BREASTMILK JAUNDICE
Clinical management of the infant with breastmilk jaundice is of considerable interest and importance. The full-term infant with breastmilk jaundice of less than 340 M/l (20 mg/dl) requires no intervention, and breastfeeding should be continued without interruption. 16 For those full-term, healthy infants with breastmilk jaundice and serum bilirubin levels between 340 and 425 M/l (20 and 25 mg/dl), closer observation of bilirubin concentrations is indicated. Some clinicians may wish to observe, whereas others may choose to complement breastfeeding with formula for 24 to 48 hours, which will reduce intestinal bilirubin absorption, or initiation of phototherapy. When serum bilirubin concentrations rise toward 425 M/l (25 mg/dl), the use of phototherapy while continuing breastfeeding, or the interruption of breastfeeding for 24 hours, substituting formula, may be indicated. Those infants with breastmilk jaundice who have developed kernicterus may have additional factors of hemolysis, infection, or a genetic alteration in bilirubin metabolism. The great majority of full-term breastfed infants who developed kernicterus had excessive weight loss of more than 10%, suggesting a period of lethargy and poor feeding, possibly secondary to the rising serum bilirubin. 17 These infants may have both breastmilk jaundice and breast-nonfeeding jaundice (see below). Thus, breastmilk jaundice may be a contributor to kernicterus, but probably only in combination with other factors. Early recognition of the breastfed infant with poor intake is essential to insure preservation of breastfeeding and to avoid excessive rises in bilirubin due to starvation. It is for this reason that breastfed infants should be examined by a well-trained clinician 2 to 3 days after hospital discharge to assess nutritional adequacy, as well as jaundice.
Unlike the full-term infant, the premature infant poses an interesting dilemma. Breastmilk, whether given directly from the breast or by cup, bottle, or tube, has been shown to provide significant protection against a variety of infections and to promote improved growth and development in the preterm infant. 18, 19 Human milk feeding increases serum bilirubin concentrations in premature infants by about 3 mg/dl over at least the first 50 days of life compared with formula-fed infants. 20 Whether this degree of increase places the breastfed premature infant at greater risk of kernicterus is unknown. There may be compensation or protection against kernicterus by prevention of infection, a factor known to increase risk for kernicterus. 21 
BREASTFEEDING (NONFEEDING) JAUNDICE
Although the optimally breastfed infant has serum bilirubin concentrations which are identical with that of the artificially fed infant during the first 5 days of life, many breastfed infants develop higher bilirubin levels during this early period of physiologic jaundice. While some authors have considered this higher level of bilirubin in the breastfed infant to be normal and expected, there is ample evidence that these elevations are, in fact, abnormal. 22, 23 Terminology is often the cause of confusion among both authors and readers. The term ''breastmilk jaundice'' should be reserved for the normally occurring prolonged unconjugated bilirubin, which has its onset after the fifth day of life. The increase in serum unconjugated bilirubin concentration seen in the first 5 days of life in some breastfed infants should be called ''breastfeeding jaundice'' or, more precisely, ''breast-nonfeeding jaundice. '' In addition to confusion in the terminology describing the relationship between human milk feeding and jaundice, there is also confusion in the literature regarding the precise definition of breastfeeding. Many papers, particularly in the earlier literature, failed to include descriptions of the breastfeeding techniques used in the study population. It is now well recognized that the volume of milk produced by the lactating mother is intimately linked to the time of onset of breastfeeding, the frequency of the breastfeeding, the completeness of emptying of the breast at each feeding, the position of the infant during nursing, and the ability of the infant to suckle effectively. Administration of water or other feeds prior to or in addition to nursing will also adversely affect the volume of milk that the breastfeeding mother will produce. 24 -27 This is especially critical during the early days of life when lactation is being established. Reduced volume of milk transfer to the infant will limit the caloric intake of the infant, producing a state of partial starvation. I use the term ''starvation'' because there is a well-described entity in the adult human and other adult mammals known as starvation jaundice. This increase of 17 to 35 M/l (1 to 2 mg/dl) in unconjugated serum bilirubin, which occurs in virtually all adults after 24 hours of fasting despite adequate water intake, has been shown to be due to an enhancement of the enterohepatic circulation of bilirubin. 11, 28 Studies in newborn rhesus monkeys demonstrated a five-fold increase in intestinal bilirubin absorption even with normal feeding regimens. 29 Starvation -even partial starvation -can be expected to further increase the intestinal absorption of bilirubin in the newborn.
The presence of large amounts of bilirubin in meconium and delay in emptying of meconium have been shown to contribute to an increase in serum bilirubin levels in the early days of life, further increasing intestinal bilirubin absorption. 30, 31 Neither breastfeeding nor reduced caloric intake increases bilirubin synthesis as measured by expired carbon monoxide. 32 Thus, the most likely explanation for the observed excessive increase in serum bilirubin in the first 5 days of life in breastfed infants in some studies is the inadequacy of milk intake due to poor breastfeeding practices and hospital policies. Support for this is found in the studies demonstrating that lower serum bilirubin concentrations in breastfed infants are associated with weight gains comparable to or better than those of artificially fed infants. 33, 34 Elevated bilirubin concentrations have been observed with greater losses from birth weight. 35 Breastfeeding frequencies of at least 11 times per day, starting with the first day, have been associated with the lowest serum bilirubin concentrations on the third to sixth days of life. 36, 37 Delay in initiation of breastfeeding beyond the first hour of life, and administration of water to infants either before initiation of breastfeeding or in addition to breastfeeding significantly reduce the frequency of breastfeeding and increase serum bilirubin concentrations. 38 While these negative effects on breastfeeding and increases in jaundice are seen primarily in the first 5 days of life, reduced caloric intake later in the newborn period can also produce marked increases in jaundice, often accompanied by dramatic weight loss, dehydration, and even kernicterus. 17 Many clinicians have observed the development of lethargy and poor feeding with high levels of bilirubin. This may further suppress caloric intake and continue a vicious cycle of increasing serum bilirubin concentration.
RELATIONSHIP OF BREAST-NONFEEDING JAUNDICE AND BREASTMILK JAUNDICE
Whereas the two entities of breastmilk jaundice and breastnonfeeding jaundice are separate phenomena, they can have an interactive effect on each other. Infants with breastmilk jaundice who manifest higher levels of bilirubin in the second and third weeks of life, often over 255 M/l (15 mg/dl), have been noted to have had relatively high serum bilirubin concentrations during the first 3 to 5 days of life due to either breast-nonfeeding jaundice, hemolysis, or unknown etiology. It has been postulated that these early, elevated bilirubin levels produce an enlarged bilirubin pool in the body. With the ingestion of mature milk and a consequent enhancement of the enterohepatic circulation, this bilirubin pool enlarges still further.
MANAGEMENT OF BREAST-NONFEEDING JAUNDICE
The great majority of breastfed infants with increased serum bilirubin levels due to breast-nonfeeding jaundice can be managed by careful evaluation of the breastfeeding and correction of the problems to insure adequate milk production and intake. Some may require temporary supplemental feeding by cup or bottle. In the full-term healthy infant, phototherapy and complementary or substitution feedings with infant formula are not needed until serum levels exceed 300 to 340 M/l (18 to 20 mg/dl). Even when slightly greater than 340 M/l (20 mg/dl), but not rising rapidly, further observation and assurance of good breastmilk intake may be all that is required. Hemolysis and other pathologic causes of hyperbilirubinemia must be ruled out, of course.
Whereas some degree of hyperbilirubinemia is normal and to be expected in the newborn period and even to be prolonged for weeks in the breastfed infant, excessive levels that place the infant at risk for bilirubin encephalopathy are certainly to be avoided, while also making every effort to preserve the breastfeeding. This can often be achieved by practicing good lactation techniques that assure an optimal milk volume and caloric intake. Thus, initiation of breastfeeding in the first hour, followed by at least 10 to 12 breastfeeds per day for the first week or two without any water or other food supplementation, and using good positioning that assures effective milk transfer to the infant will minimize weight loss to less than 7% and maintain serum bilirubin levels well under those that would cause concern about risk for kernicterus.
FUTURE RESEARCH
Future research is needed to identify the factor in mature human milk that promotes the enterohepatic circulation of bilirubin and to achieve an improved understanding of how bilirubin moves from the intestinal lumen into the mucosa. This might lead to therapeutic techniques that would allow continuation of breastfeeding while minimizing bilirubin elevations in those occasional infants whose bilirubin concentrations rise to threatening levels.
